Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Moderna's Depreciation & Amortization (CF) came in at $63 million for Q2 2026, up 10.5% from $57 million a year earlier and up 6.8% from the prior quarter.

Analysis

Moderna (MRNA) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Moderna reported Depreciation & Amortization (CF) of $241 million, up 15.9% year-over-year; for FY2025, it was $215 million, up 13.8% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 47.3% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $189 million in FY2024 (-69.6%), $621 million in FY2023 (+78.4%), $348 million in FY2022 (+50.0%) and $232 million in FY2021 (+648.4%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $36 million (Q1 2024) to $249 million (Q3 2023).
  • Year-over-year, Depreciation & Amortization (CF) has increased for three consecutive quarters, with an average decline of 3.6% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2021 (growth of 775.0%), and the weakest in Q3 2024 (a decline of 79.1%).
  • Business Quant data shows MRNA's Depreciation & Amortization (CF) at $59 million (Q1 2026), $67 million (Q4 2025) and $52 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 1.96 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 194.00 Mn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 1.93 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 98.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 1.62 Bn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn 63.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.00 Mn
Mar 31, 2026 59.00 Mn
Dec 31, 2025 67.00 Mn
Sep 30, 2025 52.00 Mn
Jun 30, 2025 57.00 Mn
Mar 31, 2025 39.00 Mn
Dec 31, 2024 60.00 Mn
Sep 30, 2024 52.00 Mn
Jun 30, 2024 41.00 Mn
Mar 31, 2024 36.00 Mn
Dec 31, 2023 202.00 Mn
Sep 30, 2023 249.00 Mn
Jun 30, 2023 92.00 Mn
Mar 31, 2023 78.00 Mn
Dec 31, 2022 80.00 Mn
Sep 30, 2022 113.00 Mn
Jun 30, 2022 76.00 Mn
Mar 31, 2022 79.00 Mn
Dec 31, 2021 78.00 Mn
Sep 30, 2021 70.00 Mn
API Access

Moderna Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MRNA&period=max&api_key=YOUR_API_KEY